How do I buy ARK Genomic ETF (ARKG) stock?

Buying ARK Genomic ETF (ARKG) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "ARKG", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy ARKG by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if ARKG is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

ARK Genomic ETF (ARKG) Stock

Q: What is the minimum investment for ARKG on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in ARK Genomic ETF from just $1. A small budget shouldn't stop you from building a US stock portfolio.

PCQ · ARKG

Trade ARKG

Key stats

Market cap: $2.76B
Volume: Loading
52-week high: $58.83
52-week low: $24.60

Source: third-party data provider, as of November 13, 2026

Technical indicators

RSI 14: 43.89
MACD 12/26/9: -0.87
EMA 9 of MACD: -0.39
MACD histogram: -0.48
SMA 50: $49.72; Price below SMA 50
EMA 50: $48.49; Price below EMA 50
SMA 200: $37.94; Price above SMA 200
EMA 200: $39.66; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

No analyst data available

Financials

Performance

No data available

Debt & Balance Sheet

No data available

Revenue to Profit

No data available

Earnings

No data available

Source: third-party data provider

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-11.6	+1.3
2022	-21.4	-4.7	-3.3	-29.2	-9.8	+1.1	+11.7	-2.4	-8.0	+1.7	-4.9	-13.7
2023	+22.1	-12.0	+0.2	-2.7	+8.3	+4.7	+11.9	-12.9	-14.6	-14.6	+19.5	+13.0
2024	-13.1	+8.5	-9.1	-17.8	+2.2	-6.4	+16.0	+1.3	+1.9	-6.9	+8.3	-11.8
2025	+9.7	-7.3	-10.3	+8.9	-3.8	+12.5	-1.4	+4.9	+12.0	+7.9	+1.7	-2.9
2026	+4.3	-2.1	-11.7	+10.3	+14.3	+21.0	-9.5	+19.2	+15.8	-3.3	-4.2

FAQ

Buying ARK Genomic ETF (ARKG) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "ARKG", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy ARKG by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in ARK Genomic ETF from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, ARK Genomic ETF (ARKG) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track ARKG's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

ARK Genomic ETF (ARKG) Stock

Key stats

Recent news

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY

Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge

Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge

TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings

TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY

Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge

Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge

TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings

TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3

Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms

Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms

Cathie Wood-Led Ark Invest's Biggest Q3 Winners And Losers — PLTR, NVDA, TXG Led While TSLA, RKLB Dragged

Cathie Wood-Led Ark Invest's Biggest Q3 Winners And Losers — PLTR, NVDA, TXG Led While TSLA, RKLB Dragged

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms

Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares

Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares

Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year

Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year

Beyond Cellular Models: Longevica Capitalizes on World's Largest In Vivo Longevity Study to Form Star-Studded Advisory Board and Unlock Human Health-and-Lifespan Pipeline

Beyond Cellular Models: Longevica Capitalizes on World's Largest In Vivo Longevity Study to Form Star-Studded Advisory Board and Unlock Human Health-and-Lifespan Pipeline

About ARK Genomic ETF

Fundamentals

Trading

Dividend

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade